HopeStage
Back to all studies
TerminatedNCT02596763

Phone-based Safety Monitoring of Baclofen Prescriptions for Addiction

Medication studyAges 18–80France
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
Abbeville and 18 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 24, 2015
Recruitment status
Terminated
Enrollment listed in the registry
239
Sponsor
University Hospital, Lille
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
France
Age range
From 18 Years to 80 Years
Official registry ID
NCT02596763
Official title
Show the full official title

Phone-based Safety Monitoring of the First Year of Baclofen Treatment for Alcohol Use Disorder: the BACLOPHONE Cohort Study

Recruitment & locations

Terminated

Abbeville · Armentières · Arras

16 more locations
  • Beauvais
  • Boulogne
  • Caen
  • Carvin
  • Clermont
  • Dunkirk
  • Ham
  • Hazebrouck
  • Lens
  • Lille
  • Roubaix
  • Rouen
  • Saint-Amand-les-Eaux
  • Saint-Pol-sur-Ternoise
  • Tourcoing
  • Valenciennes

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital, Lille, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Baclofen.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies